Tenon Medical, Inc.TNONEarnings & Financial Report
Tenon Medical, Inc. is a specialized medical device company engaged in the R&D, production and commercialization of innovative orthopedic products including surgical instruments and implant systems, with core focus on the spinal surgery and minimally invasive musculoskeletal treatment segments, primarily serving healthcare markets in the U.S. and Europe.
TNON Q4 FY2025 Key Financial Metrics
Revenue
$1.5M
Gross Profit
$1.0M
Operating Profit
$-2.9M
Net Profit
$-2.8M
Gross Margin
68.7%
Operating Margin
-193.5%
Net Margin
-191.2%
YoY Growth
92.3%
EPS
$0.07
Tenon Medical, Inc. Q4 FY2025 Financial Summary
Tenon Medical, Inc. reported revenue of $1.5M (up 92.3% YoY) for Q4 FY2025, with a net profit of $-2.8M (up 8.3% YoY) (-191.2% margin). Cost of goods sold was $464.0K, operating expenses totaled $3.9M.
Key Financial Metrics
| Total Revenue | $1.5M |
|---|---|
| Net Profit | $-2.8M |
| Gross Margin | 68.7% |
| Operating Margin | -193.5% |
| Report Period | Q4 FY2025 |
Tenon Medical, Inc. Annual Revenue by Year
Tenon Medical, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $3.9M).
Tenon Medical, Inc. Quarterly Revenue & Net Profit History
Tenon Medical, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $1.5M | +92.3% | $-2.8M | -191.2% |
| Q3 FY2025 | $1.2M | +32.2% | $-3.3M | -284.7% |
| Q2 FY2025 | $564.0K | -37.4% | $-2.8M | -491.0% |
| Q1 FY2025 | $726.0K | +1.0% | $-3.6M | -498.1% |
| Q4 FY2024 | $770.0K | -4.7% | $-3.1M | -400.9% |
| Q3 FY2024 | $887.0K | -6.0% | $-3.2M | -359.0% |
| Q2 FY2024 | $901.0K | +21.3% | $-3.8M | -424.6% |
| Q1 FY2024 | $719.0K | +66.1% | $-3.6M | -497.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $719000 | $901000 | $887000 | $770000 | $726000 | $564000 | $1.2M | $1.5M |
| YoY Growth | 66.1% | 21.3% | -6.0% | -4.7% | 1.0% | -37.4% | 32.2% | 92.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $8.0M | $6.0M | $13.0M | $9.8M | $13.4M | $11.1M | $10.4M | $10.8M |
| Liabilities | $4.4M | $5.2M | $4.8M | $3.9M | $4.0M | $4.4M | $5.6M | $5.7M |
| Equity | $3.6M | $832000 | $8.2M | $6.0M | $9.4M | $6.7M | $4.8M | $5.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.3M | $-2.4M | $-2.3M | $-2.8M | $-2.5M | $-2.2M | $-3.8M | $-2.2M |